10-Q/A

QUARTERLY REPORT

Company: Lineage Cell Therapeutics, Inc.
Filed: November 30, 2001
Period of Report: September 30, 2001
Accession Number: 0000891554-01-506735

View Document ↗ View on SEC.gov ↗